| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
Leading global solutions provider showcases new product support for Oracle cloud backup and recovery operations and achieves AWS Level 1 MSSP Competency MONTREAL, Dec. 1, 2023 /PRNewswire/ --...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
New analyses from phase 3, long-term, open-label, repeat-dose study of VALTOCO® (diazepam nasal spray) CIV will be presented Additional presentations explore anticipatory anxiety of seizures,...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that Hyung Heon Kim, President and...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies...
-
Dec 1, 2023Virtual Press Office and PR Newswire: General Trade show news
Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that...
